As of 2025-10-31, the Relative Valuation of Guardant Health Inc (GH) is (114.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 93.02 USD, the upside of Guardant Health Inc based on Relative Valuation is -223.0%.
The range of the Relative Valuation is (102.59) - (98.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 38.1x | 31.8x |
| Forward P/E multiples | 20.3x - 23.3x | 22.2x |
| Fair Price | (102.59) - (98.86) | (114.45) |
| Upside | -210.3% - -206.3% | -223.0% |
| Date | P/E |
| 2025-10-30 | -21.78 |
| 2025-10-29 | -17.03 |
| 2025-10-28 | -16.40 |
| 2025-10-27 | -16.70 |
| 2025-10-24 | -17.00 |
| 2025-10-23 | -16.34 |
| 2025-10-22 | -16.03 |
| 2025-10-21 | -15.91 |
| 2025-10-20 | -16.55 |
| 2025-10-17 | -15.43 |
| 2025-10-16 | -15.90 |
| 2025-10-15 | -15.13 |
| 2025-10-14 | -14.74 |
| 2025-10-13 | -14.55 |
| 2025-10-10 | -15.14 |
| 2025-10-09 | -15.38 |
| 2025-10-08 | -15.39 |
| 2025-10-07 | -14.95 |
| 2025-10-06 | -14.94 |
| 2025-10-03 | -14.81 |
| 2025-10-02 | -14.49 |
| 2025-10-01 | -14.77 |
| 2025-09-30 | -14.73 |
| 2025-09-29 | -14.61 |
| 2025-09-26 | -14.15 |
| 2025-09-25 | -14.18 |
| 2025-09-24 | -13.59 |
| 2025-09-23 | -14.08 |
| 2025-09-22 | -14.09 |
| 2025-09-19 | -13.94 |
| 2025-09-18 | -13.86 |
| 2025-09-17 | -13.48 |
| 2025-09-16 | -13.06 |
| 2025-09-15 | -12.91 |
| 2025-09-12 | -12.94 |
| 2025-09-11 | -13.39 |
| 2025-09-10 | -13.33 |
| 2025-09-09 | -14.01 |
| 2025-09-08 | -14.18 |
| 2025-09-05 | -14.17 |
| 2025-09-04 | -14.46 |
| 2025-09-03 | -15.33 |
| 2025-09-02 | -15.68 |
| 2025-08-29 | -15.89 |
| 2025-08-28 | -15.19 |
| 2025-08-27 | -14.97 |
| 2025-08-26 | -14.95 |
| 2025-08-25 | -14.58 |
| 2025-08-22 | -14.47 |
| 2025-08-21 | -14.44 |